Chargement en cours...
Mutant selection window of clarithromycin for clinical isolates of Helicobacter pylori
BACKGROUND: Clarithromycin-resistance is becoming a global health concern in the treatment of Helicobacter pylori (H. pylori). The mutant prevention concentration (MPC) represent the propensities of antimicrobial agents to select resistant mutants. The concentration range between the minimum inhibit...
Enregistré dans:
| Publié dans: | BMC Microbiol |
|---|---|
| Auteurs principaux: | , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
BioMed Central
2019
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6683470/ https://ncbi.nlm.nih.gov/pubmed/31382897 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12866-019-1558-8 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|